Abiopharma

News list

Bodenstedt Matthias 🔴 sold 39.1K shares of MoonLake Immunotherapeutics (MLTX) at $22.04 Transaction Date: Jun 22, 2026 | Filing ID: 071075

Full text

News bot June 23, 2026, 8:02 p.m.
🔍 Bodenstedt Matthias (Executive)

Company: MoonLake Immunotherapeutics (MLTX)

Report Date: 2026-06-22
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 39,120
Detailed Transactions and Holdings:
- Sold 39,120 shares of Class A ordinary shares, par value $0.0001 per share at $22.04 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,115,435.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
- F2: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.87 to $23.2049. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.